induction of larval tissue resorption in xenopus laevis tadpoles
TRANSCRIPT
Induction of Larval Tissue Resorption in Xenopus laevis Tadpoles by the Thyroid Hormone Receptor Agonist GC-1* J. David Furlow‡**, Hayung Yang‡, Mei Hsu‡§, Wayland Lim‡║, Davy J. Ermio‡, Grazia Chiellini¶, and Thomas S. Scanlan¶ From the ‡ Section of Neurobiology, Physiology, and Behavior, University of California, Davis, CA 95616-8519 and the ¶Departments of Pharmaceutical Chemistry and Cellular and Molecular Pharmacology, University of California, San Francisco, CA 94143-0446 Present address: §Department of Biochemistry, Dartmouth College, Hanover, New Hampshire 03755; ║St. Louis University School of Medicine, St. Louis, MO 63104 **To whom correspondence should be addressed: Section of Neurobiology, Physiology, and Behavior, University of California, One Shields Avenue, Davis, CA 95616-8519. e-mail: [email protected]. Running title: Receptor isotype regulation of Xenopus metamorphosis * This work was supported by grants from the National Institutes of Health (DK-52798 to T.S.S. and DK-55511 to J.D.F.)
by guest on April 9, 2018
http://ww
w.jbc.org/
Dow
nloaded from
2
A major challenge in understanding nuclear hormone receptor function is to determine
how the same ligand can cause very different tissue specific responses. Tissue specificity
may result from the presence of more than one receptor subtype arising from multiple
receptor genes or by alternative splicing. Recently, high affinity analogs of nuclear receptor
ligands have been synthesized that show subtype selectivity. These analogs can greatly
facilitate the study of receptor subtype-specific function in organisms where mutational
analysis is problematic or where it is desirable for receptors to be expressed in their normal
physiological contexts. We describe here the effects of the synthetic thyroid hormone
analog GC-1 on metamorphosis of the frog Xenopus laevis. The most potent natural thyroid
hormone, 3’, 3, 5- triiodothyronine or T3, shows similar binding affinity and
transactivation dose response curves for both thyroid hormone receptor isotypes,
designated TR α and TR β. GC-1, however, binds to and activates TR β at least an order of
magnitude better than TRα. GC-1 efficiently induces the larval tissue death and resorption
in premetamorphic tadpoles such as the gills and tail, two tissues that strongly induce
thyroid hormone receptor β during metamorphosis. GC-1 has less effect on the growth of
adult tissues such as the hindlimbs that express high TRα levels. The effectiveness of GC-1
in inducing tail resorption and tail gene expression correlates with increasing TRβ levels.
These results illustrate the utility of subtype selective ligands as probes of nuclear receptor
function in vivo.
by guest on April 9, 2018
http://ww
w.jbc.org/
Dow
nloaded from
3
Nuclear hormone receptors and their ligands are essential regulators of metazoan development,
reproduction, and homeostasis. One of the most dramatic nuclear receptor mediated events in
nature is amphibian metamorphosis (1,2). In the frog, metamorphosis occurs as a result of gene
expression cascades induced by thyroid hormone (TH) secreted from the developing tadpole’s
thyroid gland (3). These cascades result in dramatically different morphological responses such
as growth and differentiation of the limbs, death and resorption of the larval gills and tail, and
remodeling of a large number of larval organs for new adult functions (1). As in all vertebrates,
TH exerts its effects via a pair of TH receptor subtypes encoded by separate genes, TRα and TRβ
(4). TRs are ligand-regulated transcription factors that are thought to repress target gene
transcription in the absence of hormone and activate transcription upon hormone binding (5).
The most detailed molecular studies on amphibian metamorphosis have been done on the frog
Xenopus laevis. Xenopus TRα is expressed early in development (6,7), long before the embryo
and larval tadpole have a functional thyroid gland. Just prior to metamorphosis, xTRα is
ubiquitously expressed but particularly high levels are detected in the brain, limb buds, skin, and
other tissues that are destined to respond to TH by proliferating and differentiating into adult
organs (8,9). In contrast, much lower levels of Xenopus TRβ mRNA are detectable prior to
metamorphosis (6,10). At metamorphosis, TRβ is strongly induced by TH in larval tissues that
will die and resorb such as the tail. TRβ levels remain very low in the growing limbs, although
expression in this tissue may be highly localized (11). In remodeling tissues, such as the intestine
and cartilage of the head, TRβ mRNA is up-regulated in both dying and proliferating cells
suggesting a possible role for TRβ in both processes (8,12,13).
Xenopus TRs are extremely well conserved compared to their avian and mammalian
counterparts (4). xTRα is over 95% and 91% conserved in its DNA and ligand binding domains,
by guest on April 9, 2018
http://ww
w.jbc.org/
Dow
nloaded from
4
respectively, when compared to rat TRα. xTRβ is over 96% and 94% conserved in those
domains compared to rat TRβ. The major difference between Xenopus TR subtypes is the lack
of an amino terminal domain in xTRβ that may participate in cell specific transcriptional
activation or altered DNA binding properties in xTRα. A recently developed synthetic thyroid
hormone analog, GC-1, preferentially binds and transactivates mammalian TRβ versus TRα (14).
In human TRs, a single amino acid difference in the ligand binding pocket is responsible for this
selectivity (15), and this amino acid difference is conserved in Xenopus TRs. In vivo, GC-1
selectively decreases plasma lipids and thyroid stimulating hormone secretion without increasing
heart rate in hypothyroid rats (16). The effects of GC-1 are consistent with the known relative
expression patterns of rat TR subtypes in liver, pituitary, and heart. Recently, we have
established that Xenopus laevis metamorphosis provides a simple screening assay for the
biological activity of thyroid hormone receptor antagonists(17). Since the Xenopus and
mammalian TRs are strongly conserved, and the tissue specific responses to TH are very
dramatic, we used GC-1 to probe TR subtype function in living Xenopus laevis tadpoles during
induced metamorphosis.
MATERIALS AND METHODS
Protease protection assays -35S-methionine labeled (Amersham Pharmacia) TRα and
TRβ proteins were synthesized using TnT SP6 Coupled Wheat Germ Extract in vitro
transcription and translation system (Promega). 2µl of translated 35S labeled TR was mixed with
the indicated concentrations of T3, GC-1, NH-3, or vehicle and incubated for 30 minutes at room
temperature. 2µg of type IV Elastase (Sigma) was mixed with the TR and hormone in 96-well
plates (Costar 9017) bringing the total volume to 20µl. After a 20 minute room temperature
incubation SDS-PAGE sample buffer was added followed by four 1 minute freeze-thaw cycles.
by guest on April 9, 2018
http://ww
w.jbc.org/
Dow
nloaded from
5
Samples were boiled for 10 minutes before SDS-PAGE analysis. The SDS-PAGE gel was fixed
with 25% isopropanol and 10% acetic acid, and dried for 2 hours. The gel was exposed to a
phosphoimager screen overnight and scanned with Storm 860 (Molecular Dynamics). The bands
were quantitated using ImageQuant software.
Transient transfection assays- DNA encoding the Xenopus TRα ligand-binding domain
(amino acids 132-418) or Xenopus TRβ ligand binding domain (amino acids 85-369) was
amplified by PCR using proof reading (Pfu) DNA polymerase from cDNA encoding Xenopus
laevis TRα or TRβ using specific primers flanked by BamHI sites (5' and 3’). These fragments
were subcloned in frame with the Gal4 DNA binding domain into pSG5 Gal4 DBD vector (a gift
from Marty Privalsky, University of California, Davis) between the BamHI and BglII sites of the
dephosphorylated vector. All clones were verified by DNA sequencing (UC Davis DNA
Sequencing Facility). All cell culture media and transfection reagents were obtained from
Gibco/BRL unless otherwise indicated. XLA kidney cells or XTC fibroblast cells were seeded in
6 well tissue culture plates at a density of 1X 105 cells per well in 70% Leibovitz L-15 medium
plus 10% fetal bovine serum and gentamycin. The cells were maintained at room temperature
without CO2 supplementation. XLA cells were transfected with 50 ng pSG5 Gal4/TRa or pSG5
Gal4/TRb, 100 ng MH100X4 (a luciferase reporter gene with four UAS or Gal4 binding sites,
kindly provided by David Mangelsdorf, UT Southwestern), and 350 ng pCS2-βgalactosidase per
well(18). XTC cells were transfected with 100 ng Xenopus laevis TR expression vector
(miwTRα, miwTRβ, or miwCAT as control (19)), 100 ng TH/bZIP TRE-luciferase reporter
vector (19) and 300 ng pCS2-βgalactosidase (18) . DNA for XLA or XTC cell transfections
were mixed with 2 µl Lipofectamine 2000 (Invitrogen) per well, and added to the cells for 24
hours. Cells were allowed to recover for 12-16 hours in the culture medium, then treated for 48
by guest on April 9, 2018
http://ww
w.jbc.org/
Dow
nloaded from
6
hours with the indicated doses of T3, GC-1, or vehicle. Cells were harvested by scraping in
10mM TrisCl, pH 7.8, 150 mM NaCl, 1 mM EDTA and cell pellets were resuspended in 125 µl
reporter lysis buffer (Promega) followed by a single freeze thaw cycle. Cell extracts were
assayed for luciferase and βgalactosidase activity as described elsewhere (19).
Animal studies-Xenopus laevis tadpoles were purchased from Nasco, Inc. (Fort
Atkinson, WI) and staged according to Nieuwkoop and Faber (20). All chemicals were
purchased from Sigma unless indicated otherwise. For hormone treatments, a 1 mM stock of T3
was dissolved in 4 mM NaOH, and a 10 mM GC-1 stock was made in dimethylsulfoxide. GC-1
was synthesized as described elsewhere (14). For whole animal treatments, stage 52/53 tadpoles
were placed in 1X Steinberg’s solution with 1 mM methimazole and the indicated hormone
concentrations or appropriate vehicle and observed daily. After one week, animals were fixed in
phosphate buffered saline containing 10% formalin. Animals were photographed with a Nikon F-
5 camera and slides were scanned into Adobe Photoshop 5.0 using a Kodak RFS 3570 Plus Film
Scanner. Images were then assembled in Adobe Pagemaker 6.5.
Tail organ culture- Tadpole tails were cultured in vitro as described previously (21), with
some modifications. Staged tadpoles were pre-treated in 1X Steinberg's solution containing
gentamycin (70 µg/ml) and streptomycin (200 µg/ml) 24 hours before removal of the tail tips for
culture. The tadpoles were briefly anesthetized in water containing 0.01% MS222
(aminoesterbenzoic acid, Sigma) after which 6 mm of the tail tip was cut and placed in 1 ml of
Steinberg's solution with antibiotics and 5 µg/ml insulin in 12 well Falcon tissue culture dishes
(Becton-Dickinson). Tail tips were left in the culture media for 24 hours before the first hormone
treatment. T3 (Sigma) and GC-1 were diluted to the appropriate final concentration. The same
final dilution of the vehicle was added to control cultures. Afterwards, the culture media with
by guest on April 9, 2018
http://ww
w.jbc.org/
Dow
nloaded from
7
hormones were changed every 48 hours. The length of each tail was measured every 24 hours,
and each experimental point consisted of the mean change of 4 to 6 tails. Each experiment was
repeated twice.
RNA analysis- Tadpoles of the indicated stage were treated with T3 or GC-1 in 1X
Steinberg’s solution for 48 hours. Tails were harvested and frozen in liquid nitrogen. Total RNA
was isolated and analyzed by Northern hybridization using cDNA probes as described previously
(22). The amount of hybridized probe was determined using a Molecular Dynamics Storm
Phosphorimager and ImageQuant software and normalized to expression of the ribosomal
protein rpL8 gene (23).
RESULTS
GC-1 preferentially binds to Xenopus laevis TRβ over TRα- GC-1 is an iodine-free
thyromimetic that preferentially binds mammalian TRβ over TRα (14). In order to determine
both the relative binding affinity of GC-1 for the Xenopus TRs, protease protection assays were
performed. Protease protection assays have been used previously to both estimate binding
affinity and to reveal different conformations induced by various natural and synthetic nuclear
receptor ligands (24). In addition, the assay is performed at equilibrium and bound and free
ligands are not separated, so results tend to accurately reflect relative transcriptional activation
potency of ligands in question (25). Increasing amounts of T3, the most potent form of TH,
induce a major protected band of about 35 kDa in both xTRα and xTRβ (Fig. 2A). The binding
curves generated for xTRα and xTRβ were virtually identical (Fig. 2B). Using GC-1, a major
protected band of the same size was produced; however, GC-1 bound to xTRβ at a concentration
at least ten times lower than observed for xTRα (Fig. 2A and B). Our protease protection assay
revealed a preference of GC-1 for TRβ over TRα remarkably consistent with competitive ligand
by guest on April 9, 2018
http://ww
w.jbc.org/
Dow
nloaded from
8
binding assays used for mammalian TRs. Therefore, GC-1 is a TRβ selective ligand for Xenopus
TRs.
Activation of Xenopus laevis Thyroid Hormone Receptors by GC-1- We next tested the
ability of GC-1 to activate TRs in Xenopus laevis cells using a transient transfection assay.
Using Xenopus laevis XLA kidney cells, which express functional TRs, we examined the T3 and
GC-1 regulated transactivation properties of the TRα and TRβ ligand binding domains as Gal4
fusion proteins. The dose response curves for T3 activation of TRα and TRβ on a UAS-based
reporter gene were virtually identical, whereas GC-1 activated TRβ at lower concentrations than
TRα (Fig. 3A and 3B). The leftward shift in the GC-1 dose response curve was approximately
ten- to twenty-fold at 50% maximal induction, which essentially mirror the protease protection
assay results shown in Figure 2. We next tested the relative ability of GC-1 to activate full-
length Xenopus TRα and TRβ by transfecting expression vectors for each subtype individually
into the Xenopus XTC fibroblast cell line, which in our hands expresses a low level of functional
TRs relative to XLA cells. For example, in the absence of transfected TR, T3 or GC-1 only
activated a TRE based reporter gene by less than two-fold (see insets, Figure 3C and 3D). In
response to T3, both TRα and TRβ strongly activated reporter gene transcription. In this case,
the maximum level activation is different for TRα versus TRβ but the EC50 (about 10nM) does
not change, as has been previously reported for mammalian TR (26). When GC-1 is used, the
maximum activation is similar but the EC50 value (approximately 20 nM for TRβ vs. 200 nM
for TRα) is shifted in favor of TRα. (Fig. 3C and 3D). Therefore, in both ligand binding and
transactivation assays, GC-1 is a TRβ selective ligand for Xenopus as well as mammalian TRs.
Effect of GC-1 on Xenopus laevis tadpoles-An important advantage of metamorphosis as
an assay system is that thyroid hormone can be added directly to the rearing water, causing
by guest on April 9, 2018
http://ww
w.jbc.org/
Dow
nloaded from
9
accelerated effects that mimic what occurs during spontaneous metamorphosis. We treated
premetamorphic tadpoles (stages 52-53) with increasing doses of both T3 and GC-1. These
developmental stages are just prior to when the thyroid gland becomes active, but after the
animals are fully competent to respond to exogenous hormones. We observed the first clear
response to GC-1 at 50 nM, where obvious gill resorption and modest tail resorption are induced
(Fig. 4A.). As the dose of GC-1 is increased, progressively more gill and tail resorption occurs.
Very little change is observed in the limbs except for a loss of tissue around the forelimb buds
allowing them to extend away from the body. At high doses of GC-1 (> 200 nM), the animals
develop a beak like appearance due to the expansion of Meckel's cartilage. Finally, at 500 nM
GC-1, the treated tadpoles are considerably smaller than controls with an almost complete loss of
the tail and gills. Internally, we noted extensive resorption of the intestine beginning above 100
nM GC-1, similar to what is observed with T3 treatments above 10 nM. Like T3, the effects of
GC-1 on intact tadpoles are first apparent about two days after treatment begins, and most
animals survive the one-week treatments even at the highest doses of GC-1. In some batches of
animals, we observed limited limb growth and some widening of the brain at concentrations of
GC-1 greater than 200 nM, but these occurred infrequently and at higher concentration than
those required for tail and gill resorption that were always observed.
Our results with GC-1 contrast significantly with the results obtained with the
endogenous hormone T3. Low doses of T3 (2 nM) induced hind- and forelimbs growth and
differentiation without significant loss of tail tissue (Fig. 4A). In dorsal views (Fig. 4B),
expansion of the brain is readily observed at low T3 doses; we observe a consistent 30 to 40 %
expansion of the brain in response to 2 nM T3. Higher T3 concentrations (10 nM) induced limb
growth to a greater extent, and gill loss becomes clearly noticeable. Both growth of adult
by guest on April 9, 2018
http://ww
w.jbc.org/
Dow
nloaded from
10
structures such as the limbs and resorption of larval tissues such as the tail and gills are all
apparent at the highest doses of T3 used in these studies (50 nM). A "hunchbacked" appearance
is also apparent at these higher T3 doses that is not seen in GC-1 treated animals. This
presumably results from the accelerated development of adult dorsal muscle [Nishikawa, 1994
#480]. Toxicity was observed when T3 was used in excess of 50 nM, with many animals dying
within a few days after treatment. Thus, when GC-1 and T3 dose responses are compared, GC-1
induces death and resorption of larval tissues at lower concentrations than are required to induce
limb growth. This is completely opposite to the developmental program induced by the natural
hormone T3 where growth responses generally precede larval tissue death and resorption.
The sensitivity of tadpole tails to GC-1 increases with increasing TRβ expression-Since
higher levels of GC-1 than T3 were required to cause tissue responses in premetamorphic
tadpoles, we next tested whether the efficiency of GC-1 in inducing larval cell death would
improve in later developmental stages when TRβ levels are significantly elevated. TRβ protein
expression increases eight- to ten-fold as tadpoles develop from premetamorphosis (prior to
thyroid gland maturation) to metamorphic climax when tail resorption commences in earnest
(27). On the other hand, despite a modest increase in TRα message, TRα protein levels remain
constant throughout metamorphosis. Therefore we predicted a modest increase in sensitivity to
T3 but a large increase in sensitivity to the TRβ selective ligand GC-1 at two developmental
stages: premetamorphic stages 52-54 with low TRβ levels and prometamorphic stages 57-58
when TRβ levels were nearly maximal but tail resorption had not yet begun.
We first established that isolated tail tips from premetamorphic tadpoles would resorb in a T3
dose responsive and reproducible manner (Fig. 5A). Maximal resorption rates occurred at
concentrations above 32 nM T3. We then measured the efficiency of tail resorption in response
by guest on April 9, 2018
http://ww
w.jbc.org/
Dow
nloaded from
11
to increasing T3 and GC-1 at stages 53/54 and 57/58. Tails were measured after six days
treatment, when the control tails were still healthy and there were clear differences in the
response to various doses of hormones (Fig. 5B). Stage 57-58 tails were modestly more sensitive
to T3 (about two fold at 50% resorption) than stage 52-54 tails. Strikingly, the stage 57-58 tails
were over twelve-fold more sensitive to GC-1 than the stage 52-54 tails when the doses required
to induce 50% resorption are compared. This increased sensitivity to GC-1 is especially
apparent at low doses of GC-1 (50 nM) where there is no response in young tadpoles but a robust
response is observed in older tadpoles.
Induction of TH response genes by T3 and GC-1-A large collection of TH response genes
has been cloned from Xenopus laevis tadpole tails (28), as well as from several other tissues (29-
31). Tail TH response genes include rapidly induced early genes that generally encode
transcription factors and delayed genes that mostly encode membrane bound, secreted, or
intracellular proteases and extracellular matrix components and receptors (28,32). Delayed gene
expression is more tissue specific than early gene expression and is especially strong in
fibroblasts under the epidermis and between muscle fibers of the tail and in the gills (13). We
have analyzed the induction of tail TH response genes by increasing doses of T3 and GC-1,
again using stages of development with different levels of TRβ expression.
xBTEB (33) is a zinc finger transcription factor whose expression is typical of early gene
responses to both T3 and GC-1 (Fig. 6 A and B). xBTEB is quite sensitive to T3, since it is
induced by as low as 1 nM T3 in stage 54 tadpoles. The induction of xBTEB by T3 at stage 57
is similar. GC-1 induces xBTEB above 100nM in stage 54 tadpoles; however, at stage 57/58,
GC-1 is unable to induce xBTEB expression above baseline. Gene 12, TH/bZIP, and TRβ itself
are other early genes that show a similar dose response profile to T3 and GC-1 as xBTEB (data
by guest on April 9, 2018
http://ww
w.jbc.org/
Dow
nloaded from
12
not shown). We next looked at the delayed class of tail response genes, exemplified by the
membrane bound protease fibroblast activation protein α (FAPα) (32) (Fig. 6C and D). First, a
five-to -ten fold higher level of T3 is required to activate delayed genes like FAPα than early
genes like xBTEB. In response to GC-1, FAPα mRNA is first induced above baseline at 100 nM,
with a similar dose response curve to xBTEB. Strikingly, FAPα becomes more, not less,
sensitive to GC-1 in older animals that are expressing more TRβ. A clear induction of FAPα is
seen in response to as low as 20 nM GC-1 in stage 57-58 animals. Other genes in this delayed
class that show the same pattern of responses are the secreted matrix metalloproteinase
collagenase-3 and the intracellular protease pepE (data not shown). We also noted that the dose
response curves for delayed gene expression closely parallels both the T3 and GC-1 dose
response curves in tail culture assays, further implicating these genes as key players in the
process of tail resorption.
DISCUSSION
A recently developed TRβ selective agonist, GC-1, preferentially induces a subset of TH
regulated developmental programs in Xenopus laevis tadpoles, namely the death and resorption
of larval tissues. Thus, we provide compelling evidence for different functional roles of the two
TR subtypes during metamorphosis, extending earlier expression studies that were strictly
correlative (8,13,28). Our results agree well with known TR isotype gene expression in that GC-
1 poorly induces TRα rich tissues but is most effective in tissues that have low TRα levels but
strongly induce TRβ. TRβ expression in the tail is particularly high in fibroblasts under the skin
and around the notochord that also strongly express delayed tail response genes like FAPα. The
pronounced effects of GC-1 on gill and tail resorption are intriguing in light of recent
experiments on the expression of TRα and TRβ in various salamander species. Obligatorily
by guest on April 9, 2018
http://ww
w.jbc.org/
Dow
nloaded from
13
neotenic species like Necturus are unable to complete metamorphosis such that the external gills
and tail fins of these animals are resistant to TH even though they have fully developed limbs.
Interestingly, they express TRα in those tissues but there is no detectable baseline or inducible
TRβ message, even though an apparently normal TRβ gene exists in the genome (34).
Most tail response genes are induced by similarly high doses of GC-1 in premetamorphic
animals (>100 nM) but show very different responses at later developmental stages when TRβ is
the predominant receptor isotype. Based on these results, we propose that there are two classes
of genes in terms of TR subtype control. In young animals, sufficient TRβ must be induced via
TRα to activate delayed genes, but other early genes like xBTEB and gene 12 are also being
induced in parallel. At later stages, only the delayed genes become more sensitive to both T3 and
GC-1 indicating that this gene class, at least in the tail, is preferentially controlled by TRβ. Our
tail culture results are also most consistent with at least a partial requirement for activation for
xTRα to induce sufficient xTRβ levels for a response in larval tissues like the tail. Indeed, the
xTRβ gene contains a strong thyroid hormone response element near its transcription start site
(35,36), and TRβ can be induced in tadpoles even in the presence of protein synthesis inhibitors
(10). However, there are other possibilities to account for the differences in tissue sensitivity to
T3 and GC-1. There may be less efficient uptake of GC-1 than T3 from the rearing media in
young tadpoles or stage differences in the metabolism of the ligands. In rats, GC-1 accumulates
in the liver to a higher degree than in the heart, potentiating its TR subtype selective properties
(16). In this study, we deliberately focused on limb versus tail responses rather than internal
organs due to equal access of each tissue to the media.
Although our results are consistent with a dominant role for TRβ in larval tissue death
and resorption, we cannot completely rule out a role for TRβ in formation of adult structures
by guest on April 9, 2018
http://ww
w.jbc.org/
Dow
nloaded from
14
during metamorphosis. For instance, TRβ activation may be important in the differentiation of
adult cells after several rounds of TRα mediated proliferation have occurred. TRβ mRNA is
detectable in certain remodeling tissues undergoing both resorption and growth such as head
cartilage and the intestine (8,12). In addition, the effects of GC-1 on premetamorphic tadpoles
are perhaps more dramatic than expected based on the dose response profiles of transient
transfection assays alone. It is possible that inappropriately timed TRβ activation may antagonize
TRα function. The estrogen inducible progesterone receptor antagonizes estrogen receptor
function in the mammalian uterus (37). Another interpretation of our results is that the effects of
GC-1 on premetatmorphic tadpoles may simply reflect where each isotype is most abundant as
the tissue responds. In this model, the two TR isotypes differ quantitatively but not qualitatively.
In order to test this possibility, transgenic approaches are now available in Xenopus where it
should be possible to express xTRβ in xTRα dominated tissues and vice versa depending on the
availability of appropriate tissue-specific promoters.
There is growing evidence in other animals for isotype specific functions of nuclear
receptors. In insects, ecdysone receptor (EcR) diversity is generated by alternate promoter usage
of the same gene to create different amino terminal transactivation domains (38). Three EcR
subtypes in Drosophila melanogaster are expressed in different ratios in different tissues, which
correlate with different tissue fates at metamorphosis (38). Specific EcR-B1 mutations prevent
salivary gland histolysis and development of a subset of imaginal disks which cannot be rescued
by overexpression of the EcR-A subtype (39). In vertebrates, knockout studies of each TR gene
alone and in combination in mice have demonstrated both overlapping and distinct functions for
the two TR genes (40). For instance, proper functional development of the inner ear appears to
require TRβ (41) and TRα appears to play a more dominant role in TH control of resting heart
by guest on April 9, 2018
http://ww
w.jbc.org/
Dow
nloaded from
15
rate and body temperature (42,43). However, other processes such as negative feedback control
of the thyroid stimulating hormone gene were at least partially affected in both TR knockouts
(40). It is possible that TR subtype specific function is more distinct in taxa other than mammals.
Certainly, the study of receptor signaling during development is easier in model systems with
externally developing embryos. Our findings illustrate the utility of subtype-selective ligands as
probes of nuclear receptor function in vivo, and demonstrate the potential of natural systems such
as amphibian metamorphosis as simple bioassays for the development of selective agonists and
antagonists of thyroid hormone receptors.
Acknowledgements-The authors would like to thank Jock Hamilton for photography and
the Privalsky laboratory for providing CV-1 cells and for advice on their transient transfection.
We also thank Phuoc Le, Sherman Lau, and Yvette Chu for excellent technical assistance.
REFERENCES 1. Dodd, M. H. I., and Dodd, J. M. (1976) in Physiology of the Amphibia (Lofts, B., ed), pp.
467–599, Academic Press, New York 2. Tata, J. R. (1998) Cell Res 8, 259-272 3. Brown, D. D., Wang, Z., Kanamori, A., Eliceiri, B., Furlow, J. D., and Schwartzman, R.
(1995) Recent Prog Horm Res 50, 309-315 4. Yaoita, Y., Shi, Y. B., and Brown, D. D. (1990) Proc Natl Acad Sci U S A 87, 7090-7094 5. Zhang, J., and Lazar, M. A. (2000) Annu Rev Physiol 62, 439-466 6. Yaoita, Y., and Brown, D. D. (1990) Genes Dev 4, 1917-1924 7. Banker, D. E., Bigler, J., and Eisenman, R. N. (1991) Mol Cell Biol 11, 5079-5089 8. Berry, D. L., Rose, C. S., Remo, B. F., and Brown, D. D. (1998) Dev Biol 203, 24-35 9. Kawahara, A., Baker, B. S., and Tata, J. R. (1991) Development 112, 933-943 10. Kanamori, A., and Brown, D. D. (1992) J Biol Chem 267, 739-745 11. Fairclough, L., and Tata, J. R. (1997) Dev Growth Differ 39, 273-283 12. Shi, Y. B., Su, Y., Li, Q., and Damjanovski, S. (1998) Int J Dev Biol 42, 107-116 13. Berry, D. L., Schwartzman, R. A., and Brown, D. D. (1998) Dev Biol 203, 12-23 14. Chiellini, G., Apriletti, J. W., Yoshihara, H. A., Baxter, J. D., Ribeiro, R. C., and Scanlan,
T. S. (1998) Chem Biol 5, 299-306 15. Wagner, R. L., Huber, B. R., Shiau, A. K., Kelly, A., Cunha Lima, S. T., Scanlan, T. S.,
Apriletti, J. W., Baxter, J. D., West, B. L., and Fletterick, R. J. (2001) Mol Endocrinol 15, 398-410
by guest on April 9, 2018
http://ww
w.jbc.org/
Dow
nloaded from
16
16. Trost, S. U., Swanson, E., Gloss, B., Wang-Iverson, D. B., Zhang, H., Volodarsky, T., Grover, G. J., Baxter, J. D., Chiellini, G., Scanlan, T. S., and Dillmann, W. H. (2000) Endocrinology 141, 3057-3064
17. Lim, W., Nguyen, N. H., Yang, H. Y., Scanlan, T. S., and Furlow, J. D. (2002) J Biol Chem
18. Turner, D. L., and Weintraub, H. (1994) Genes Dev 8, 1434-1447 19. Furlow, J. D., and Brown, D. D. (1999) Mol Endocrinol 13, 2076-2089 20. Nieuwkoop, P. D., and Faber, J. (1994) Normal Tables of Xenopus laevis (Daudin),
Garland Publishing, New York 21. Tata, J. R., Kawahara, A., and Baker, B. S. (1991) Dev Biol 146, 72-80 22. Furlow, J. D., Berry, D. L., Wang, Z., and Brown, D. D. (1997) Dev Biol 182, 284-298 23. Shi, Y. B., and Liang, V. C. (1994) Biochim Biophys Acta 1217, 227-228 24. Yoh, S. M., and Privalsky, M. L. (2002) Methods Mol Biol 202, 129-152 25. Blumberg, B., Bolado, J., Jr., Derguini, F., Craig, A. G., Moreno, T. A., Chakravarti, D.,
Heyman, R. A., Buck, J., and Evans, R. M. (1996) Proc Natl Acad Sci U S A 93, 4873-4878
26. Hollenberg, A. N., Monden, T., and Wondisford, F. E. (1995) J Biol Chem 270, 14274-14280
27. Eliceiri, B. P., and Brown, D. D. (1994) J Biol Chem 269, 24459-24465 28. Wang, Z., and Brown, D. D. (1993) J Biol Chem 268, 16270-16278 29. Shi, Y. B., and Brown, D. D. (1993) J Biol Chem 268, 20312-20317 30. Buckbinder, L., and Brown, D. D. (1992) J Biol Chem 267, 25786-25791 31. Denver, R. J., Pavgi, S., and Shi, Y. B. (1997) J Biol Chem 272, 8179-8188 32. Brown, D. D., Wang, Z., Furlow, J. D., Kanamori, A., Schwartzman, R. A., Remo, B. F.,
and Pinder, A. (1996) Proc Natl Acad Sci U S A 93, 1924-1929 33. Furlow, J. D., and Kanamori, A. (2002) Endocrinology 143, 3295-3305 34. Safi, R., Begue, A., Hanni, C., Stehelin, D., Tata, J. R., and Laudet, V. (1997) J Mol Evol
44, 595-604 35. Ranjan, M., Wong, J., and Shi, Y. B. (1994) J Biol Chem 269, 24699-24705 36. Machuca, I., Esslemont, G., Fairclough, L., and Tata, J. R. (1995) Mol Endocrinol 9, 96-
107 37. Tong, W., and Pollard, J. W. (1999) Mol Cell Biol 19, 2251-2264 38. Talbot, W. S., Swyryd, E. A., and Hogness, D. S. (1993) Cell 73, 1323-1337 39. Bender, M., Imam, F. B., Talbot, W. S., Ganetzky, B., and Hogness, D. S. (1997) Cell 91,
777-788 40. Forrest, D., and Vennstrom, B. (2000) Thyroid 10, 41-52 41. Forrest, D., Hanebuth, E., Smeyne, R. J., Everds, N., Stewart, C. L., Wehner, J. M., and
Curran, T. (1996) Embo J 15, 3006-3015 42. Johansson, C., Gothe, S., Forrest, D., Vennstrom, B., and Thoren, P. (1999) Am J Physiol
276, H2006-2012 43. Wikstrom, L., Johansson, C., Salto, C., Barlow, C., Campos Barros, A., Baas, F., Forrest,
D., Thoren, P., and Vennstrom, B. (1998) Embo J 17, 455-461
by guest on April 9, 2018
http://ww
w.jbc.org/
Dow
nloaded from
17
FIGURE LEGENDS
FIG. 1: Structures of T3 and GC-1. Chemical structures of 3, 5, 3’-triidothyronine, or T3, and
the isotype selective agonist GC-1.
FIG. 2: GC-1 binds preferentially to Xenopus laevis thyroid hormone receptor β. A. In vitro
translated, 35S-labeled xTRα or xTRβ were incubated with the indicated nM concentrations of T3
or GC-1, then treated with 4 µg of elastase. The resulting bands were resolved by 12% SDS-
PAGE. I, input. B. T3 binding curves for xTRα (circles) and xTRβ (squares) were generated by
quantitation of the protected bands shown in A, and expressed as a percentage of the maximally
protected bands. C. GC-1 binding curves for xTRα (circles) and xTRβ (squares) were generated
by quantitation of the protected bands shown in A, and expressed as a percentage of the
maximally protected bands. Error bars in B and C represent standard deviation.
FIG. 3. GC-1 preferentially activates Xenopus laevis TRβ versus TRα relative in transient
transfection assays. A and B. A UAS-containing promoter driving luciferase reporter gene
expression was co-transfected into Xenopus laevis kidney epithelial cells (XLA) along with
expression vectors for Xenopus laevis TRα/Gal4 (circles) or TRβ/Gal4 (squares) fusion
proteins, and the cells were treated with increasing concentrations of T3 (A) or GC-1 (B).
Luciferase activity was normalized to constitutive β-galactosidase activity. C and D. A TRE-
containing minimal promoter driving luciferase reporter gene expression was co-transfected in
Xenopus laevis XTC cells with expression vectors for full-length Xenopus TRα (circles) or TRβ
(squares), and cells were treated with in creasing concentrations of T3 (C) or GC-1 (D).
Induction of the TRE-based reporter gene by T3 or GC-1 without co-transfection of either TR
by guest on April 9, 2018
http://ww
w.jbc.org/
Dow
nloaded from
18
expression vector is shown in the insets of C and D. Luciferase activity was normalized to
constitutive β-galactosidase activity. Each data point was determined in triplicate, and error bars
represent SD.
FIG. 4. GC-1 strongly induces the loss of larval tissues in premetamorphic (stage 52/53)
tadpoles, whereas T3 induces both the death of larval tissues and growth of adult tissues
like the hind and forelimbs. A, top panels: Tadpoles treated for one week with the indicated
GC-1 concentrations, ventral views. G, gills; HL, Hindlimbs. Bottom panels, Tadpoles treated
for one week with the indicated T3 concentrations, also ventral views. B. Same treated animals
as in A, dorsal views. Top panels, GC-1 treated animals. Br, brain; G, Gills. Bottom panels, T3
treated animals.
FIG. 5. The efficiency of GC-1 induced tail resorption in vitro correlates with TRβ but not
TRα levels. A. Tail tips from stages 53/54 cultured in vitro show a dose dependent resorption in
response the indicated concentration of T3 compared to untreated tail tips. The extent of tail
resorption is expressed as the % of tail length remaining in hormone treated cultures compared to
cultures treated with vehicle alone. B. Tails were obtained from stage 53/54 tadpoles (open
symbols) or stage 57-58 tadpoles (filled symbols). Squares, T3; Circles, GC-1. Error is
expressed as SEM.
FIG. 6. Northern blot analysis of thyroid hormone response genes induced by T3 and GC-
1. Two thyroid hormone response genes, BTEB (A and B) and FAPα (C and D), were assayed
for induction by increasing doses of T3 (A and C, squares) or GC-1 (B and D, circles). RNA
by guest on April 9, 2018
http://ww
w.jbc.org/
Dow
nloaded from
19
was analyzed from tails of tadpoles at stages 53/54 (open symbols) or stages 57/58 (closed
symbols). Northern data was normalized by stripping the blots and reprobing for constitutive
rpL8 expression, and shown as a % of the maximum expression for each set of dose response
curves on a given blot.
by guest on April 9, 2018
http://ww
w.jbc.org/
Dow
nloaded from
HO
I
OCO2H
NH2
H
I
I
T3
HO
H3C
CH3
O CO2H
GC-1
Figure 1
by guest on April 9, 2018
http://ww
w.jbc.org/
Dow
nloaded from
0
20
40
60
80
100
120
-11 -10 -9 -8 -7 -6
Log [T3]
% M
ax
. B
ind
ing
B.
0
0
20
40
60
80
100
120
-10 -9 -8 -7
Log [GC-1]
% M
ax. B
ind
ing
C.
0
I 0 0.1 1 10 100 1000 nM T3
I 0 1 2 5 10 20 50 100 200 nM GC-1
TRα
TRβ
TRα
TRβ
A.
Figure 2 by guest on A
pril 9, 2018http://w
ww
.jbc.org/D
ownloaded from
0
2000
4000
6000
8000
-10 -9 -8 -7 -6
0
2000
4000
6000
8000
-10 -9 -8 -7 -6
A.
B.
Figure 3
[Log T3, M]
[Log GC-1, M]
Rel
ativ
e Lu
c A
ctiv
ityR
elat
ive
Luc
Act
ivity
by guest on April 9, 2018
http://ww
w.jbc.org/
Dow
nloaded from
0
40
80
120
160
-11 -10 -9 -8 -7 -6
0
40
80
120
160
0 nM 100 nM
No TR
0
100
200
300
400
500
0 nM 100 nM
No TR
C.
D.
[Log T3, M]
[Log GC-1, M]
Figure 3, cont.R
elat
ive
Luc
Act
ivity
Rel
ativ
e Lu
c A
ctiv
ity
0
100
200
300
400
500
-10 -9 -8 -7 -6 -5
by guest on April 9, 2018
http://ww
w.jbc.org/
Dow
nloaded from
nM GC-1: 0 50 100 200 500
nM T3: 0 2 10 50
A.G
HL
B.
nM T3: 0 2 10
nM GC-1: 0 500
G Br
Tail
by guest on April 9, 2018
http://ww
w.jbc.org/
Dow
nloaded from
0
20
40
60
80
100
0 1 2 3 4 5 6 7 8
2
nM T3
Days after first T3 treatment
% T
ail R
emai
ning
4
8
16
3264
128
A.
0
25
50
75
100
% T
ailr
eman
ing
rela
tive
to c
ontr
ols
0 -8 -7 -6
log [Hormone]
-8.7
B.
Figure 5
by guest on April 9, 2018
http://ww
w.jbc.org/
Dow
nloaded from
0
25
50
75
100
Perc
ent m
ax. i
nduc
tion
-8
-7.5 -7
-6.5 -6
Log [GC-1]
FAPα0
25
50
75
100
Perc
ent m
ax. i
nduc
tion
-9
-8.5 -8
-7.5 -7
-6.5
Log [T3]
FAPα
0 00
25
50
75
100
Perc
ent m
ax. i
nduc
tion
-9 -8.5 -8 -7.5 -7 -6.5
Log [T3]
0
0
25
50
75
100
Perc
ent m
ax. i
nduc
tion
-8
-7.5 -7
-6.5 -6
Log [GC-1]
0BTEB BTEB
A. B.
C. D.
Figure 6
by guest on April 9, 2018
http://ww
w.jbc.org/
Dow
nloaded from
and Thomas S. ScanlanJ. David Furlow, Hayung Yang, Mei Hsu, Wayland Lim, Davy J. Ermio, Grazia Chiellini
hormone receptor agonist GC-1Induction of larval tissue resorption in Xenopus laevis tadpoles by the thyroid
published online March 30, 2004J. Biol. Chem.
10.1074/jbc.M402847200Access the most updated version of this article at doi:
Alerts:
When a correction for this article is posted•
When this article is cited•
to choose from all of JBC's e-mail alertsClick here
by guest on April 9, 2018
http://ww
w.jbc.org/
Dow
nloaded from